Thelansis

Prosthetic Joint Infection (PJI) Market Outlook Thelansis’s “Prosthetic Joint Infection (PJI) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Prosthetic Joint Infection (PJI) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest im...

Prosthetic Joint Infection (PJI) Market Outlook Thelansis’s “Prosthetic Joint Infection (PJI) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Prosthetic Joint Infection (PJI) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Prosthetic Joint Infection (PJI) Overview Prosthetic joint infection (PJI), also known as periprosthetic infection, involves the joint prosthesis and adjacent tissue. Periprosthetic joint infection (PJI) is a severe and challenging complication after joint replacement. Due to the lack of consensus on the management of PJI, physicians often face uncertainty. However, errors in diagnosis and treatment can resu...

 Prosthetic joint infection (PJI), also known as periprosthetic infection, involves the joint prosthesis and adjacent tissue. Periprosthetic joint infection (PJI) is a severe and challenging complication after joint replacement. Due to the lack of consensus on the management of PJI, physicians often face uncertainty. However, errors in diagnosis and treatment can result in increased healthcare costs, reinfection, or mortality. While most joint arthroplasties provide pain-free function, a minority of patients will experience device failure and require additional surgery at some point during the life of the device. Reasons for aseptic failure include loosening at the bone cement interface, periprosthetic fracture, fracture of the prosthetic material, wear, implant malposition, dislocation-instability, or material fatigue. ·        The cumulative number of knee and hip replacement cases in the USA ranges from 3 million to 4 million. The incidence of per...